RI
DFTX icon

RTW Investments’s Definium Therapeutics DFTX Stock Holding History

RTW Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Buy
400,000
+100,000
+33% +$2.47M 0.16% 61
2026
Q1 		$5.67M Hold
300,000
– – 0.06% 80
2025
Q4 		$4.02M Buy
+300,000
New +$3.71M 0.04% 83

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

RTW Investments's DFTX Position: Q2 2026 in Review

RTW Investments increased its Definium Therapeutics (DFTX) stake by 33% in Q2 2026, buying an estimated $2.47M and bringing the position to 400,000 shares worth $18.8M. The position accounts for 0.16% of the portfolio, ranked #61.

RTW Investments first reported a position in DFTX in Q4 2025 and has held it in 3 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • RTW Investments held 400,000 shares of Definium Therapeutics worth $18.8M as of Q2 2026.
  • RTW Investments bought 100,000 Definium Therapeutics shares in Q2 2026, an estimated $2.47M.
  • Definium Therapeutics made up 0.16% of RTW Investments's portfolio in Q2 2026, its #61 holding.
  • RTW Investments first reported a position in Definium Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.